BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4758424)

  • 1. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D; Teien A; Bjerkelund CJ
    Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; NĂ¼esch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in biologic availability of digoxin from four preparations.
    Lindenbaum J; Mellow MH; Blackstone MO; Butler VP
    N Engl J Med; 1971 Dec; 285(24):1344-7. PubMed ID: 5121186
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin tablet bioavailability: single-dose and steady-state assessment.
    Preibisz JJ; Butler VP; Lindenbaum J
    Ann Intern Med; 1974 Oct; 81(4):469-74. PubMed ID: 4412826
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
    Shaw TR; Howard MR; Hamer J
    Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143
    [No Abstract]   [Full Text] [Related]  

  • 12. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
    DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability of digoxin.
    Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF; O'Grady J; Sabey GA; Bye C
    Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of different lots of digoxin tablets from the same manufacturer.
    Lindenbaum J
    Clin Pharmacol Ther; 1975 Mar; 17(3):296-301. PubMed ID: 1091397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin prescribing in general practice 1967--77.
    Pedoe HD
    Lancet; 1978 Oct; 2(8096):931-3. PubMed ID: 81940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of digoxin tablets.
    Lindenbaum J
    Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.
    Wagner JG
    Am Heart J; 1974 Aug; 88(2):133-8. PubMed ID: 4601506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.